400 related articles for article (PubMed ID: 18467578)
1. AIDS/HIV. A STEP into darkness or light?
Moore JP; Klasse PJ; Dolan MJ; Ahuja SK
Science; 2008 May; 320(5877):753-5. PubMed ID: 18467578
[No Abstract] [Full Text] [Related]
2. New hope for an AIDS vaccine.
Robinson HL
Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
[TBL] [Abstract][Full Text] [Related]
3. AIDS research. Did Merck's failed HIV vaccine cause harm?
Cohen J
Science; 2007 Nov; 318(5853):1048-9. PubMed ID: 18006711
[No Abstract] [Full Text] [Related]
4. Disappointing data scuttle plans for large-scale AIDS vaccine trial.
Cohen J
Science; 2002 Mar; 295(5560):1616-7. PubMed ID: 11872804
[No Abstract] [Full Text] [Related]
5. India targets local HIV strain in test of AIDS vaccine.
Jayaraman KS
Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
[No Abstract] [Full Text] [Related]
6. Candidate AIDS vaccines.
Graham BS; Wright PF
N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026
[No Abstract] [Full Text] [Related]
7. [Nucleic acid vaccines for study in AIDS patients are approved. Vaccines of genetic molecules--humoral and cellular immune response].
Hobom B
Fortschr Med; 1995 Dec; 113(35-36):12. PubMed ID: 8582688
[No Abstract] [Full Text] [Related]
8. Merck's HIV vaccine flop brings vectors under closer scrutiny.
Ledford H
Nat Biotechnol; 2008 Jan; 26(1):3-4. PubMed ID: 18182999
[No Abstract] [Full Text] [Related]
9. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
10. HIV-1/AIDS vaccine development: are we in the darkness.
Qiu C; Xu JQ
Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
[No Abstract] [Full Text] [Related]
11. HIV-1 T-cell vaccines: evaluating the next step.
Pantaleo G
Lancet Infect Dis; 2008 Feb; 8(2):82-3. PubMed ID: 18060842
[No Abstract] [Full Text] [Related]
12. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy. Oral route to Holy Grail?
Palù G; Parolin C
Gene Ther; 2003 Jan; 10(1):1-2. PubMed ID: 12525828
[No Abstract] [Full Text] [Related]
14. IAVI begins trials of AIDS vaccine.
Expert Rev Vaccines; 2003 Dec; 2(6):731. PubMed ID: 15282843
[No Abstract] [Full Text] [Related]
15. Tepid endorsement for HIV vaccine trial.
Science; 1995 Feb; 267(5200):966. PubMed ID: 7863340
[No Abstract] [Full Text] [Related]
16. Adenovirus as vector for HIV: efficacy and safety issues.
Natuk RJ; Wade MS; Chengalvala M; Murthy KK; Chanda PK; Murthy SC; Bhat BM; Bhat R; Dheer SK; Mizutani S
Dev Biol Stand; 1995; 84():153-6. PubMed ID: 7796948
[No Abstract] [Full Text] [Related]
17. AIDS research. Debate begins over new vaccine trials.
Cohen J
Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
[No Abstract] [Full Text] [Related]
18. [The virus can not yet be eradicated. "HIV-infected patients cannot be completely cured"].
Hellbom K
Krankenpfl J; 1998; 36(7-8):274. PubMed ID: 9775853
[No Abstract] [Full Text] [Related]
19. [AIDS vaccine: who should be selected for the test?].
Marcus U
Fortschr Med; 1995 Nov; 113(32):16-7. PubMed ID: 8543269
[No Abstract] [Full Text] [Related]
20. The rational design of an AIDS vaccine.
Douek DC; Kwong PD; Nabel GJ
Cell; 2006 Feb; 124(4):677-81. PubMed ID: 16497577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
